Katja Fink Selected Research

Katja Fink Research Topics

Disease

29	Infections 01/2021 - 10/2003
19	Dengue (Dengue Fever) 12/2019 - 10/2009
7	Virus Diseases (Viral Diseases) 01/2020 - 09/2004
4	Viremia 12/2016 - 04/2009
3	Coinfection 12/2016 - 01/2011
3	Vesicular Stomatitis 01/2008 - 10/2003
2	COVID-19 11/2020 - 01/2020
2	Yellow Fever 07/2020 - 11/2018
2	Flavivirus Infections 01/2019 - 01/2019
1	Pneumonia (Pneumonitis) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2021
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 11/2018
1	Japanese Encephalitis 11/2018
1	Zika Virus Infection 04/2017
1	Inflammation (Inflammations) 09/2014
1	Fever (Fevers) 01/2011
1	Human Influenza (Influenza) 08/2010
1	Persistent Infection 10/2008
1	Reinfection 10/2008
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 09/2004

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 11/2020 - 09/2004
11	AntibodiesIBA 01/2020 - 01/2008
10	Neutralizing AntibodiesIBA 01/2021 - 09/2004
7	Immunoglobulin G (IgG)IBA 03/2015 - 10/2003
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2012
5	CytokinesIBA 01/2019 - 10/2009
4	Antiviral Agents (Antivirals)IBA 01/2019 - 02/2014
4	InterferonsIBA 01/2019 - 01/2017
3	Dengue VaccinesIBA 01/2019 - 07/2014
3	Immunoglobulin M (IgM)IBA 04/2009 - 10/2003
2	ChemokinesIBA 01/2022 - 01/2012
2	Subunit VaccinesIBA 01/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2014
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 08/2010
2	triphosphoric acid (triphosphate)IBA 04/2014 - 02/2014
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 05/2021
1	nanolucIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Peptides (Polypeptides)IBA 12/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2019
1	EpitopesIBA 12/2019
1	AntigensIBA 12/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2019
1	LigandsIBA 01/2019
1	Monoclonal AntibodiesIBA 04/2017
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 04/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	Capsid Proteins (Capsid Protein)IBA 03/2015
1	Recombinant Fusion ProteinsIBA 03/2015
1	aluminum sulfate (alum)IBA 03/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2014
1	Phosphotransferases (Kinase)IBA 10/2014
1	Interleukin-10 (Interleukin 10)IBA 09/2014
1	Interferon Type IIBA 07/2014
1	ProdrugsIBA 02/2014
1	balapiravirIBA 02/2014
1	CytidineIBA 02/2014
1	4'-azidocytidineIBA 02/2014
1	Viral ProteinsIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Aluminum Oxide (Sapphire)IBA 12/2012
1	Broadly Neutralizing AntibodiesIBA 09/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	HLA-DR Antigens (HLA-DR)IBA 08/2010
1	Interleukin-15 (Interleukin 15)IBA 08/2010
1	Clodronic Acid (Clodronate)IBA 10/2009
1	Liposomes (Liposome)IBA 10/2009
1	Immunoglobulin A (IgA)IBA 10/2008
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2003

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Aftercare (After-Treatment) 02/2014
1	Immunotherapy 04/2009